article thumbnail

Sanofi forges $30m alliance with digital health firm DarioHealth

pharmaphorum

Originally set up with a focus on diabetes, Dario has added capabilities in hypertension, weight management, and musculoskeletal and behavioural health in the intervening years, for example by acquiring musculoskeletal wearable company Upright Technologies and digital behavioural health specialist wayForward last year.

article thumbnail

Applied Virtual Reality in Healthcare: A comprehensive book on medical XR

pharmaphorum

Still, it can be challenging to acquire a complete picture of how this technology is used overall in medicine. “I Walter says pharma can wield many of the book’s insights to improve its portfolios and help advance immersive technology in medicine. How pharma can leverage XR.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Orexo eyes opioid use disorder app launch before year-end

pharmaphorum

“Modia is designed to close the gap as it relates to the access and receipt of quality, evidence-based therapeutic interventions and behavioural health services for individuals with OUD who participate in outpatient treatment with MAT,” said Michael Sumner, Orexo’s chief medical officer.

article thumbnail

5 Telehealth Providers to Rely on During Covid-19

Find Me Cure

Valley Health is a Telehealth service provider that also shows commitment to fighting the pandemic by offering a Covid-19 assessment. Their regular services include behavioural health, MAT, family medicine, internal medicine, and paediatrics. Teladoc Health. Their locations are in West Virginia.

Doctors 69
article thumbnail

IVRHA 2022: Exhibiting pioneers of medical XR

pharmaphorum

Alongside those organisations sat well-known companies and agencies, such as the National Institute of Health (NIH), Johnson & Johnson, HDMS of CVS Health, Microsoft, Meta, and HP, determined to be part of the fast-growing immersive reality industry. In 2021, the behavioural health company and Sumitomo Dainippon Pharma Co.

article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

2020 was a psychological and systemic tipping point for telehealth, adoption of which will accelerate in 2021 as it becomes the norm, in the process driving new self-service approaches to medicine and participation-based reimbursement models. Mental health worsens – digital tools continue to fill the gap.

article thumbnail

Drug discovery predictions: Analysis and insight 

Drug Discovery World

DDW shared a global data analysis from Phesi, which showed the extent of the impact from the war in Ukraine on clinical development. As more tools are developed in this space, a greater diversity of patients will be accessible to researchers as geographical and other barriers to participation, are lowered.